Skip to main content

AI Bias Analysis

4 models · Takes ~15 seconds

Stat News

Seaport’s IPO adventure, obesity pill battles, and Makary’s troubles

Seaport’s IPO adventure, obesity pill battles, and Makary’s troubles
ShareXFacebook

This week on "The Readout LOUD" podcast: Seaport Therapeutics’ successful IPO, obesity pill battles, and the FDA commissioner's White House troubles.

S

Source

Stat News

Read full article at Stat News

Opens original article in a new tab

Advertisement

Related Health Stories

5-Year Data Support Top-Down Therapy in Crohn's Disease
MedPage Today

5-Year Data Support Top-Down Therapy in Crohn's Disease

(MedPage Today) -- A "top-down" approach of early aggressive therapy for Crohn's disease continued to achieve better outcomes versus a conventional accelerated "step-up" approach, long-term follow-up data from the PROFILE trial showed. At 5-year...

Read more →
Advertisement